La Agencia Europea del Medicamento (EMA) ha publicado su informe anual, el correspondiente a 2013, en que el Comité de Medicamentos de Uso Humano (CHMP) autorizó 81 fármacos, 24 más que en 2012.
Etiquetas: Access to clinical trial data, Administrative aspects, Advancin public and animal health in 2013, Annual report 2013, At the forefront of a global debate, Collaboration with HTA bodies, EMA, Engagement of patients and healthcare professionals for safer use of medicines, European Medicines Agency, Health, Human medicines, Implementation of new legislation, Increasing availability throughout the European Union, Informe Anual 2013, Inspections and compliance, Integrating new tasks, Key figures in 2013, London, Medicine, Other highlights, Rapidly evolving relationship, Reorganisation of the EMA, Reshaping for the future, salud, Sanidad, Sciene, Significant recommendations in 2013, Supporting new approaches to medicines development, The European medicines regulatory network A, Veterinary medicines.
Hazte premium para descargar